IL6 and myeloid sarcoma: IL-6 and CRP may contribute to MS risk [14], and a sharp increase in FFA can cause both insulin resistance (IR) in the liver, increase the expression of proinflammatory cytokines such as IL-6, and stimulate the liver to secrete CRP [15].